Mycotic Keratitis and Orbital Mucormycosis

Two Distinct Diseases (shared fungal etiology only)

Mycotic keratitis: localized corneal infection, trauma-related. Orbital mucormycosis: severe invasive extension of rhino-orbital-cerebral disease (Mucormycosis topic) — much greater severity, hold separate despite shared “fungal eye disease” framing.

Mycotic Keratitis

Organisms: filamentous fungi — Fusarium, Aspergillus classic. Less common: Candida (assoc. with pre-existing ocular surface disease/chronic topical steroid use, not trauma). KEY RISK FACTOR: ocular trauma with VEGETABLE/PLANT MATTER (thorn, branch) — spores directly inoculated into stroma. Explains AGRICULTURAL/RURAL predominance — important India epi point given agricultural workforce.

Clinical: pain, photophobia, corneal infiltrate (like bacterial) BUT distinctive: FEATHERY-EDGED infiltrate + SATELLITE LESIONS (smaller surrounding infiltrates) — should raise fungal suspicion when seen.

Diagnosis: corneal scraping → KOH wet-mount (hyphae visualization, same technique as General Mycology) + culture on Sabouraud’s. Treatment: TOPICAL NATAMYCIN = first-line for filamentous fungal keratitis (ophthalmology-specific antifungal, not used elsewhere in curriculum) or voriconazole (topical/systemic) alt. Prolonged course (weeks) vs bacterial keratitis.

Orbital Mucormycosis

= EXTENSION of rhino-orbital-cerebral mucormycosis INTO ORBIT (full biology/angioinvasion/DKA association = Mucormycosis topic) — not a separate disease, this topic’s specific orbital manifestation. Context: substantial COVID-19-associated surge in India, many with orbital involvement.

Clinical: periorbital swelling, PROPTOSIS, OPHTHALMOPLEGIA (restricted eye movement — orbital muscle/nerve involvement), VISION LOSS (direct optic nerve invasion/compression OR central retinal artery occlusion from angioinvasion extending to orbital vessels). Same angioinvasive mechanism as general Mucormycosis (black eschar, rapid destruction), here applied to orbital vessels.

→ Orbital/vision-threatening extension = urgent trigger for aggressive management (surgical debridement + systemic amphotericin B, per Mucormycosis topic). Vision loss + intracranial extension risk = most severe threats in rhino-orbital-cerebral spectrum — sharp contrast in urgency/severity vs localized mycotic keratitis above.

Two Genuinely Distinct Fungal Ocular Diseases

Mycotic keratitis and orbital mucormycosis are two mechanistically and clinically distinct fungal ocular diseases sharing only their fungal aetiology in common: mycotic (fungal) keratitis is a comparatively localized corneal infection typically following ocular trauma, while orbital mucormycosis is a genuinely far more severe, invasive, potentially life-threatening extension of the rhino-orbital-cerebral mucormycosis process already covered under Mucormycosis — despite the shared “fungal eye disease” framing, the two differ sharply in severity and mechanism.

Mycotic Keratitis

Fungal keratitis is caused predominantly by filamentous fungi — classically Fusarium and Aspergillus species — and, less commonly, Candida species (more associated with keratitis in the setting of pre-existing ocular surface disease or chronic topical corticosteroid use rather than trauma). The genuinely, specifically important, classic risk factor is ocular trauma involving vegetable/plant matter (a thorn, branch, or similar organic material injuring the cornea) — a real, high-yield, specifically testable point of clinical association, reflecting how filamentous fungal spores present on plant material are directly inoculated into the corneal stroma at the moment of injury, explaining fungal keratitis’s disproportionate occurrence in agricultural settings and rural populations, a genuinely important epidemiological point in India’s specific context given the country’s large agricultural workforce. Clinically, fungal keratitis presents similarly to bacterial keratitis in its general features (pain, photophobia, corneal infiltrate) but with some genuinely distinctive examination features worth remembering: a feathery-edged corneal infiltrate with satellite lesions (smaller, separate infiltrates surrounding the main lesion) is classically described and, when present, should specifically raise suspicion for a fungal rather than bacterial cause. Diagnosis relies on corneal scraping for KOH wet-mount microscopy (directly visualizing fungal hyphae, the same general KOH technique covered under General Mycology) and culture on Sabouraud’s dextrose agar; treatment uses topical natamycin (specifically effective and classically first-line against filamentous fungal keratitis, genuinely worth remembering as a comparatively ophthalmology-specific antifungal not commonly used elsewhere in this curriculum) or topical/systemic voriconazole as an alternative, with the disease’s course typically genuinely prolonged (weeks) compared with bacterial keratitis.

Orbital Mucormycosis

Orbital mucormycosis represents the extension of rhino-orbital-cerebral mucormycosis (full biology, angioinvasive mechanism, and classic diabetic-ketoacidosis association covered under Mucormycosis) specifically into the orbit — this is genuinely, deliberately, not a separate independent disease but rather this topic’s specific ocular/orbital manifestation of that same broader invasive fungal process, worth understanding as a direct extension rather than a distinct entity, and genuinely important given the substantial COVID-19-pandemic-associated surge in rhino-orbital-cerebral mucormycosis cases seen in India, many of which had prominent orbital involvement. Clinically, orbital extension presents with periorbital swelling, proptosis (forward eye displacement), ophthalmoplegia (restricted eye movement from orbital muscle/nerve involvement), and, critically, potential vision loss from direct optic nerve invasion or compression, or from central retinal artery occlusion secondary to the organism’s characteristic angioinvasion extending into the orbital vasculature — this angioinvasive vascular occlusion mechanism is precisely the same process, applied to orbital vessels specifically, that produces the black, necrotic eschar and rapid tissue destruction described generally under Mucormycosis, and orbital/vision-threatening extension is precisely why rhino-orbital-cerebral mucormycosis management (aggressive surgical debridement plus systemic amphotericin B, as covered under Mucormycosis) is pursued so urgently and aggressively once any orbital or ocular signs appear — genuine vision loss, alongside the risk of further intracranial extension, represents one of the most severe, immediate threats within the broader rhino-orbital-cerebral disease spectrum, distinguishing it sharply in urgency and severity from the comparatively localized, non-life-threatening mycotic keratitis discussed above.